Effect of the Histone Deacetylases Inhibitors on the Differentiation of Stem Cells in Bone Damage Repairing and Regeneration

Author(s): Qing Zhao, Kun Ji, Tiancong Wang, Guifeng Li, Wei Lu*, Jun Ji*.

Journal Name: Current Stem Cell Research & Therapy

Volume 15 , Issue 1 , 2020

Become EABM
Become Reviewer

Abstract:

Tissue damage repairing and regeneration is a research hot topic. Tissue engineering arises at the historic moment which is a defect repair compound composed of seed cells, tissue engineering scaffolds, and inducing factors. Stem cells have a limited growth period in vitro culture, and they have a pattern of replicating ageing, and these disadvantages are limiting the applications of stem cells in basic research and clinical treatment. The enhancement of stem cell differentiation ability is a difficult problem to overcome, and it is possible to enhance the differentiation ability of stem cells through histone modification so as to provide a more robust foundation for damage repairing and regeneration. Studies have shown that Histone Deacetylases (HDAC) inhibitors can improve mesenchymal stem cells in vitro induced in different directions, conversion efficiency, increasing the feasibility and safety of stem cell therapy and tissue engineering, to offer reference to promote the stem cell therapy in clinical application. Therefore, this paper mainly focusing on the usage and achievements of the deacetylase inhibitors in stem cell differentiation studies and their use and prospects in repair of bone tissue defects.

Keywords: Tissue engineering, histone acetylation, histone deacetylases inhibitors, cell differentiation, stem cells, seed cells.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 15
ISSUE: 1
Year: 2020
Page: [24 - 31]
Pages: 8
DOI: 10.2174/1574888X14666190905155516
Price: $65

Article Metrics

PDF: 12